{"id":"W2905794790","doi":"10.1007/s13555-018-0279-5","title":"Clinical Goals and Barriers to Effective Psoriasis Care","year":2018,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Université de Sherbrooke; Dermatrials Research; Probity Medical Research","funders":"Cilag; Allergan; Medac; Astellas Pharma; Glenmark Pharmaceuticals; National Psoriasis Foundation; Pfizer; Incyte; Dermira; Sun Pharma; Regeneron Pharmaceuticals; University of Connecticut; Eli Lilly and Company; Cardiff University; Celgene; LEO Pharma; Ortho Dermatologics; Gilead Sciences; Sanofi; GlaxoSmithKline; Galderma; Bristol-Myers Squibb; Meiji Seika Pharma; Coherus Biosciences; UCB Pharma; Valeant Pharmaceuticals International; Amgen","keywords":"Psoriasis; Pace; Medicine; Disease; Intensive care medicine; Alternative medicine; Business; Family medicine; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05028491,0.0003766862,0.0006313692,0.0008930949,0.004193519,0.01217781,0.002257303,0.006091343,0.007277345],"category_scores_gemma":[0.08571006,0.0004602188,0.0005707779,0.0007384282,0.007102673,0.006333821,0.01019729,0.01305864,0.001919504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00690067,"about_ca_system_score_gemma":0.03328898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007162657,"about_ca_topic_score_gemma":0.006625327,"domain_scores_codex":[0.9484521,0.03133646,0.00375169,0.002281921,0.007411053,0.00676679],"domain_scores_gemma":[0.9282511,0.02686423,0.004789774,0.001809882,0.01142222,0.02686278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0002453919,0.000869444,0.03167305,0.00369497,0.0001427154,0.001360092,0.02818792,0.001374071,0.002343502,0.2438713,0.3546657,0.3315718],"study_design_scores_gemma":[0.0001710841,0.0004759198,0.02870004,0.00897081,0.000086905,0.00186171,0.09318558,0.001494121,0.001438601,0.2589498,0.6044448,0.0002204438],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.01380035,0.01057885,0.002573476,0.9532832,0.001437831,0.0001014456,0.0000845392,0.00005620118,0.01808409],"genre_scores_gemma":[0.7792931,0.02241734,0.01861244,0.1706805,0.002590201,0.0006873942,0.000301398,0.0001570925,0.005260509],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05028491,"threshold_uncertainty_score":0.2659352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01353686459235835,"score_gpt":0.2924971744397164,"score_spread":0.278960309847358,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}